HBx mutations emerged during antiviral therapy: a new face of a multifaceted HBV protein?

Hepatol Int. 2020 Dec;14(6):944-946. doi: 10.1007/s12072-020-10116-z. Epub 2020 Dec 3.

Authors

Bin Zhou^{1

2}, Weimeng He¹, Jinlin Hou³

Affiliations

¹ Department of Infectious Diseases, Nanfang Hospital, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Southern Medical University, Guangzhou, China.
² Hepatology Unit of Shenzhen Hospital, Southern Medical University, Shenzhen, China.
³ Hepatology Unit of Shenzhen Hospital, Southern Medical University, Shenzhen, China. jlhousmu@163.com.

PMID: 33269421
DOI: 10.1007/s12072-020-10116-z

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Hep G2 Cells
Hepatitis B virus* / genetics
Humans
Mutation
Viral Proteins / genetics
Virus Replication

Substances

Antiviral Agents
Viral Proteins

Grants and funding